Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg(6),D-Trp(7,9),N(me)Phe(8)]-substance P (6–11)-induced growth inhibition

Documenti analoghi

• [Arg(6), D-Trp(7,9), N(me)Phe(8)]-substance P (6–11) (antagonist G) inducesP-1 transcription and sensitizes cells to chemotherapy
  di: MacKinnon, A C, et al.
  Pubblicazione: (2000)
• [Arg(6),D-Trp(7,9),N(me)Phe(8)]-substance P (6–11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism
  di: MacKinnon, A C, et al.
  Pubblicazione: (1999)
• Targeting V(1A)-vasopressin receptors with [Arg(6), D-Trp(7,9), N(me)Phe(8)]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies
  di: MacKinnon, Alison C, et al.
  Pubblicazione: (2009)
• Expression of V(1A) and GRP receptors leads to cellular transformation and increased sensitivity to substance-P analogue-induced growth inhibition
  di: MacKinnon, A C, et al.
  Pubblicazione: (2005)
• Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P.
  di: Jones, D. A., et al.
  Pubblicazione: (1996)